Glioblastoma multiforme: Can neural stem cells deliver the therapeutic payload and fulfill the clinical promise?

Expert Review of Neurotherapeutics

Volumn 11, Issue 6, 2011, Pages 775-777

  Ahmed, Atique U ^a   Lesniak, Maciej S ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

cell carrier; gene therapy; glioblastoma; glioma; mesenchymal stem cells; neural stem cells; oncolytic virus; stem cells

Indexed keywords

CANCER ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY;

ANTINEOPLASTIC ACTIVITY; BLOOD BRAIN BARRIER; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER GENE THERAPY; CELL HOMING; DRUG STABILITY; GLIOBLASTOMA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STEM CELL; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; REVIEW; TREATMENT RESPONSE;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; DRUG DELIVERY SYSTEMS; GLIOBLASTOMA; HUMANS; NEURAL STEM CELLS;

EID: 79958251748     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.11.65     Document Type: Review

References (13)

1. Aboody KS, Brown A, Rainov NG, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc. Natl Acad. Sci. USA 97(23), 12846-12851 (2000).
2. Benedetti S, Pirola B, Pollo B, et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat. Med. 6(4), 447-450 (2000). (Pubitemid 30208163)
3. Joo KM, Park IH, Shin JY, et al. Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases. Mol. Ther. (3), 570-575 (2009).
4. Aboody KS, Bush RA, Garcia E, et al. Development of a tumor-selective approach to treat metastatic cancer. PLoS One 1, e23 (2006).
5. Sims TL Jr, Hamner JB, Bush RA, et al. Neural progenitor cell-mediated delivery of osteoprotegerin limits disease progression in a preclinical model of neuroblastoma bone metastasis. J. Pediatr. Surg. 44(1), 204-210; discussion 210-211 (2009).
6. Einstein, O, Ben-Hur T. The changing face of neural stem cell therapy in neurologic diseases. Arch. Neurol. 65(4), 452-456 (2008). (Pubitemid 351549952)
7. Ahmed AU, Thaci B, Alexiades NG, et al. Neural stem cell-based carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthoptopic mouse model of human glioblastoma. Mol. Ther. (2011) (In press).
8. Ahmed AU, Alexiades NG, Lesniak MS. The use of neural stem cells in cancer gene therapy: predicting the path to the clinic. Curr. Opin. Mol. Ther. 12(5), 546-552 (2010).
9. Le S FDA approves f?irst human neural stem cell clinical trial to treat brain tumors. Synapse 54(1), 1-2 (2010).
10. Tyler MA, Ulasov IV, Sonabend AM, et al. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo. Gene Ther. 16(2), 262-278 (2009).
11. Frank RT, Edmiston M, Kendall SE, et al. Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies. PLoS One 4(12), e8314 (2009).
12. Balyasnikova IV, Ferguson SD, Sengupta S, Han Y, Lesniak MS. Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma. PLoS One 5(3), e9750 (2010).
13. Aboody KS, Najbauer J, Danks MK. Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther. 15(10), 739-752 (2008). (Pubitemid 351627357)